Predicting the range of plasma carbamazepine concentrations in patients with epilepsy.
A statistical model is proposed for predicting the range of plasma carbamazepine concentrations after administration of a controlled-release formulation at steady state. The model is based on previous clinical studies in patients with epilepsy. The predicted range may be used to monitor and adjust treatment in a patient.